NPI registry status
Active
2026 NPPES data Nurse Practitioner NPI 1811418577 AGNP-C
Verify on CMS → Jose Romelito Causin, AGNP-C
Nurse Practitioner in West Hollywood, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 87,700 in Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
294
Medicare Part D claims · 66 beneficiaries · Nurse Practitioner avg: 1K
MIPS score
87.7/100
▲ 5 pts above national avg 83.1 · Above neutral
Industry payments
$122.93
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Jose Romelito Causin, AGNP-C reported a CMS MIPS final score of 87.7/100 - above the 83.1 national average - and filed 294 Medicare Part D claims in 2023.
- 87.7/100
- MIPS score · +5 vs avg
- 294
- Part D claims, 2023
- $122.93
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jose Romelito Causin, AGNP-C's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
88 Top 46% higher than 54% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jose Romelito Causin, AGNP-C sits
This provider among nurse practitioner peers
Across the 13,476 nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Jose Romelito Causin, AGNP-C writes more Part D claims than 44% of them and scores higher on MIPS quality than 55% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nurse practitioner peer from a representative sample of 60; the gold marker is Jose Romelito Causin, AGNP-C. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Jose Romelito Causin, AGNP-C?
High performer (top quartile)Primary specialty
Nurse Practitioner
Medicare Part D claims
294 73% vs specialty avg
MIPS final score
87.7/100 4.6 pts vs avg
Specialty distribution in California
How Nurse Practitioner compares to other specialties among California providers
Medicare quality performance, MIPS
Jose Romelito Causin, AGNP-C's 2023 MIPS final score plotted against the Nurse Practitioner national average
- MIPS Final Score
- 87.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nurse Practitioner) - 87.7/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jose Romelito Causin, AGNP-C appears in the CMS NPPES registry as a Nurse Practitioner provider holding AGNP-C credentials at 8700 BEVERLY BLVD, West Hollywood, CA, 90048, with a listed phone of (310) 423-1160. NPI 1811418577 was issued on 07/03/2017.
Medicare Part D records for calendar year 2023 show 294 prescription claims written by this provider, covering 66 Medicare beneficiaries and totaling roughly $626K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.7/100 for the 2023 performance year (Quality 80.9, Cost 49.4), compared with the national average of 83.1.
Nurse Practitioner is a high-volume specialty nationwide, with 87,700 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1811418577 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | AGNP-C |
| Gender | Male |
| NPI Issued | 07/03/2017 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
87.6775
Final Score
Avg: 83.1
80.8666
Quality
49.4287
Cost
99
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jose Romelito Causin, AGNP-C. Source: openpaymentsdata.cms.gov.
Total received
$123
Largest payer
Janssen Biotech, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Jose Romelito Causin, AGNP-C. To verify Jose Romelito Causin, AGNP-C's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
294
Total Claims
$626K
Total Drug Cost
66
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 354
- Total Day Supply
- 9,712
- Generic Drug Cost
- $34K
- Antibiotic Claims
- 30
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 3.88
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jose Romelito Causin, AGNP-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Acyclovir
Acyclovir
35 claims
- Valacyclovir
Valacyclovir
26 claims
- Pantoprazole Sodium
Pantoprazole Sodium
21 claims
- Sulfamethoxazole-T…
Sulfamethoxazole-Trimethoprim
17 claims
- Atovaquone
Atovaquone
15 claims
| Drug | Claims |
|---|---|
| Acyclovir | 35 |
| Valacyclovir Valacyclovir Hcl | 26 |
| Pantoprazole Sodium | 21 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 |
| Atovaquone | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How Jose Romelito Causin, AGNP-C fits within the Nurse Practitioner landscape nationally.
87,700
Nurse Practitioner Providers in US
56
States with Nurse Practitioner
1,084
Avg Claims per Provider
Jose Romelito Causin, AGNP-C's 294 claims are below the specialty average of 1,084.
Nearby Nurse Practitioner Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Causin.
Dr. Barbara Aaronson
RN/NURSE PRACTITONER
Los Angeles, CA
Dr. Albert Aba
AGNP
San Francisco, CA
Venice Ababat
Colton, CA
Dr. Martha Ababneh
CNA
El Monte, CA
Dr. Chelsea Abad
CRNP, AGPCNP - BC
Duarte, CA
Compare Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Jose Romelito Causin, AGNP-C's specialty? ▼
Jose Romelito Causin, AGNP-C specializes in Nurse Practitioner and practices in West Hollywood, California. Credentials: AGNP-C.
How much does Jose Romelito Causin, AGNP-C prescribe under Medicare Part D? ▼
In 2023, Jose Romelito Causin, AGNP-C wrote 294 Medicare Part D claims totaling $626K in drug costs for 66 beneficiaries.
What is Jose Romelito Causin, AGNP-C's Medicare quality score? ▼
Jose Romelito Causin, AGNP-C has a CMS MIPS Final Score of 87.7/100 (Quality: 80.9, Cost: 49.4). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jose Romelito Causin, AGNP-C located? ▼
Jose Romelito Causin, AGNP-C is located at 8700 BEVERLY BLVD, West Hollywood, CA, 90048. Phone: (310) 423-1160.
What is Jose Romelito Causin, AGNP-C's NPI number? ▼
Jose Romelito Causin, AGNP-C's National Provider Identifier (NPI) is 1811418577, issued on 07/03/2017.
How many Nurse Practitioner providers are there in the US? ▼
There are 87,700 Nurse Practitioner providers across 56 states in the US. The average Nurse Practitioner provider writes 1,084 Medicare Part D claims per year.
What drugs does Jose Romelito Causin, AGNP-C prescribe most often? ▼
Based on 2023 Medicare Part D data, Jose Romelito Causin, AGNP-C's most frequently prescribed drugs include Acyclovir, Valacyclovir, Pantoprazole Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jose Romelito Causin, AGNP-C accept Medicare? ▼
Jose Romelito Causin, AGNP-C appears in CMS Medicare data with 294 Part D claims and 66 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jose Romelito Causin, AGNP-C's credentials? ▼
Jose Romelito Causin, AGNP-C's NPI is 1811418577 with credentials AGNP-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.